CHISON MEDICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 93.9205 million yuan, a year-on-year decrease of 4.56%
According to the Zhitong Finance APP, CHISON MEDICAL released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 343 million yuan, a year-on-year decrease of 5.27%. The net profit attributable to shareholders of the listed company was 93.9205 million yuan, a year-on-year decrease of 4.56%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 86.9666 million yuan, a year-on-year decrease of 2.69%
According to the Zhitong Finance APP, CHISON MEDICAL (688358.SH) released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 343 million yuan, a year-on-year decrease of 5.27%. The net profit attributable to shareholders of the listed company was 93.9205 million yuan, a year-on-year decrease of 4.56%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 86.9666 million yuan, a year-on-year decrease of 2.69%
